CPC A23L 2/56 (2013.01) [A23L 2/60 (2013.01); A23L 27/2054 (2016.08); A23L 27/21 (2016.08); A23L 27/31 (2016.08); A23L 27/88 (2016.08); A23L 33/15 (2016.08); A23L 33/175 (2016.08); A23V 2002/00 (2013.01); A23V 2200/33 (2013.01); A23V 2250/0638 (2013.01); A23V 2250/0644 (2013.01); A23V 2250/0652 (2013.01); A23V 2250/154 (2013.01); A23V 2250/161 (2013.01); A23V 2250/2108 (2013.01); A23V 2250/705 (2013.01); A23V 2250/706 (2013.01); A23V 2250/708 (2013.01); A23V 2250/7046 (2013.01); A23V 2250/7052 (2013.01); A23V 2250/7056 (2013.01)] | 22 Claims |
1. A method for increasing energy levels of a subject, for reducing fatigue or drowsiness in a subject, or for increasing alertness in a subject, the method comprising administering to the subject a composition comprising about 1 mg to about 1000 mg of compound (14):
or a pharmaceutically or nutraceutically acceptable salt thereof.
|